MSI Financial Services’s Arcturus Therapeutics ARCT Stock Holding History

MSI Financial Services’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2K	Hold	120	–	–	﹤0.01%	3460
2016 Q3	$2K	Hold	120	–	–	﹤0.01%	3460
2016 Q2	$4K	Hold	120	–	–	﹤0.01%	3220
2016 Q1	$3K	Hold	120	–	–	﹤0.01%	3366
2015 Q4	$5K	Buy	120 +6	+5%	+$270	﹤0.01%	3054
2015 Q3	$5K	Buy	+114	New	+$6K	﹤0.01%	2379

Other funds holding ARCT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

MSI Financial Services's ARCT Position: Q4 2016 in Review

MSI Financial Services held its Arcturus Therapeutics (ARCT) position steady in Q4 2016 at 120 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

MSI Financial Services first reported a position in ARCT in Q3 2015 and has held it in 6 quarters since. The position peaked at $5K in Q4 2015. 42 funds tracked by Wall St. Rank hold ARCT as of Q4 2016.

MSI Financial Services held 120 shares of Arcturus Therapeutics worth $2K as of Q4 2016.
MSI Financial Services left its Arcturus Therapeutics share count unchanged in Q4 2016.
Arcturus Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3460 holding.
MSI Financial Services first reported a position in Arcturus Therapeutics in Q3 2015 and has held it in 6 quarters since.
MSI Financial Services's Arcturus Therapeutics position peaked at $5K in Q4 2015.
42 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.